{"id":2497,"date":"2021-03-02T13:10:46","date_gmt":"2021-03-02T12:10:46","guid":{"rendered":"https:\/\/www.igb.cnr.it\/?page_id=2497"},"modified":"2025-07-08T10:35:04","modified_gmt":"2025-07-08T08:35:04","slug":"emilia-caputo","status":"publish","type":"page","link":"https:\/\/www.igb.cnr.it\/index.php\/emilia-caputo\/","title":{"rendered":"Emilia Caputo"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"2497\" class=\"elementor elementor-2497\" data-elementor-settings=\"{&quot;ha_cmc_init_switcher&quot;:&quot;no&quot;}\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-12e4e074 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"12e4e074\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;_ha_eqh_enable&quot;:false}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-top-column elementor-element elementor-element-608d93eb\" data-id=\"608d93eb\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-53772bd elementor-widget elementor-widget-bdt-member\" data-id=\"53772bd\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;_animation&quot;:&quot;none&quot;}\" data-widget_type=\"bdt-member.bdt-phaedra\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"bdt-member skin-phaedra bdt-transition-toggle\">\n\t\t\t\n\t\t\t\t<div class=\"bdt-member-photo-wrapper\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"bdt-member-photo\">\n\t\t\t\t\t\t<div class=\"\">\n\t\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2024\/02\/x-cv.jpg\" title=\"x cv\" alt=\"x cv\" loading=\"lazy\" \/>\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t<\/div>\n\n\t\t\t\n\t\t\t<div class=\"bdt-member-overlay bdt-overlay-default bdt-position-cover bdt-transition-fade bdt-position-z-index\">\n\t\t\t\t<div class=\"bdt-member-desc bdt-position-center bdt-text-center\">\n\t\t\t\t\t<div class=\"bdt-member-content bdt-transition-slide-top-small\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-66 elementor-top-column elementor-element elementor-element-3aa32a0a\" data-id=\"3aa32a0a\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-731f567b elementor-widget elementor-widget-heading\" data-id=\"731f567b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Emilia Caputo<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7e509587 elementor-widget elementor-widget-spacer\" data-id=\"7e509587\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-43f9c336 elementor-widget elementor-widget-text-editor\" data-id=\"43f9c336\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h3><strong><span style=\"color: #006293\">Researcher<\/span><\/strong><\/h3><div><p><strong>\u00a0 <img decoding=\"async\" class=\"alignnone wp-image-2318\" src=\"http:\/\/www.igb.cnr.it\/wp-content\/uploads\/2021\/02\/Telefono-icona.png\" alt=\"\" width=\"17\" height=\"17\" srcset=\"https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2021\/02\/Telefono-icona.png 512w, https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2021\/02\/Telefono-icona-300x300.png 300w, https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2021\/02\/Telefono-icona-150x150.png 150w, https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2021\/02\/Telefono-icona-270x250.png 270w, https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2021\/02\/Telefono-icona-510x510.png 510w\" sizes=\"(max-width: 17px) 100vw, 17px\" \/> +39 081 6132307\/446\/455 \u00a0 <img decoding=\"async\" class=\"alignnone wp-image-2317\" src=\"http:\/\/www.igb.cnr.it\/wp-content\/uploads\/2021\/02\/email-icona.png\" alt=\"\" width=\"19\" height=\"19\" srcset=\"https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2021\/02\/email-icona.png 512w, https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2021\/02\/email-icona-300x300.png 300w, https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2021\/02\/email-icona-150x150.png 150w, https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2021\/02\/email-icona-270x250.png 270w, https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2021\/02\/email-icona-510x510.png 510w\" sizes=\"(max-width: 19px) 100vw, 19px\" \/> emilia.caputo@igb.cnr.it<\/strong><\/p><p><strong>Molecular Oncology<\/strong><\/p><p><strong>Keywords: <\/strong>Breast Cancer Patient-derived Organoids; Multicellular Spheroids (MCSs); Breast Cancer; gp17\/GCDFP-15\/SABP\/PIP; BRAF-driven Cancers; Melanoma; Drug Resistance in Cancer; Targeted Therapy; Biomarker Discovery.<\/p><p><strong>\u00a0<\/strong><\/p><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-2d7e67ad elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"2d7e67ad\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;_ha_eqh_enable&quot;:false}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-669a2c8e\" data-id=\"669a2c8e\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-46716ff3 elementor-widget elementor-widget-eael-adv-tabs\" data-id=\"46716ff3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"eael-adv-tabs.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t        <div data-scroll-on-click=\"no\" data-scroll-speed=\"300\" id=\"eael-advance-tabs-46716ff3\" class=\"eael-advance-tabs eael-tabs-horizontal eael-tab-auto-active \" data-tabid=\"46716ff3\">\n            <div class=\"eael-tabs-nav\">\n                <ul class=\"\" role=\"tablist\">\n                                            <li id=\"research-interest\" class=\"inactive eael-tab-item-trigger eael-tab-nav-item\" aria-selected=\"true\" data-tab=\"1\" role=\"tab\" tabindex=\"0\" aria-controls=\"research-interest-tab\" aria-expanded=\"false\">\n                            \n                            \n                            \n                                                            <span class=\"eael-tab-title title-after-icon\" >Research Interest<\/span>                                                    <\/li>\n                                            <li id=\"selected-publications\" class=\"inactive eael-tab-item-trigger eael-tab-nav-item\" aria-selected=\"false\" data-tab=\"2\" role=\"tab\" tabindex=\"-1\" aria-controls=\"selected-publications-tab\" aria-expanded=\"false\">\n                            \n                            \n                            \n                                                            <span class=\"eael-tab-title title-after-icon\" >Selected Publications<\/span>                                                    <\/li>\n                                            <li id=\"professional-experience\" class=\"inactive eael-tab-item-trigger eael-tab-nav-item\" aria-selected=\"false\" data-tab=\"3\" role=\"tab\" tabindex=\"-1\" aria-controls=\"professional-experience-tab\" aria-expanded=\"false\">\n                            \n                            \n                            \n                                                            <span class=\"eael-tab-title title-after-icon\" >Professional Experience<\/span>                                                    <\/li>\n                                            <li id=\"research-group\" class=\"inactive eael-tab-item-trigger eael-tab-nav-item\" aria-selected=\"false\" data-tab=\"4\" role=\"tab\" tabindex=\"-1\" aria-controls=\"research-group-tab\" aria-expanded=\"false\">\n                            \n                            \n                            \n                                                            <span class=\"eael-tab-title title-after-icon\" >Research Group<\/span>                                                    <\/li>\n                                    <\/ul>\n            <\/div>\n            \n            <div class=\"eael-tabs-content\">\n\t\t        \n                    <div id=\"research-interest-tab\" class=\"clearfix eael-tab-content-item inactive\" data-title-link=\"research-interest-tab\">\n\t\t\t\t        <p>My research program focuses on cancer, by integrating broad disciplines centered on translational sciences. My key research activities include:<\/p><p><strong><img decoding=\"async\" class=\"alignnone wp-image-12539\" src=\"http:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/images.png\" alt=\"\" width=\"23\" height=\"23\" srcset=\"https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/images.png 225w, https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/images-150x150.png 150w\" sizes=\"(max-width: 23px) 100vw, 23px\" \/> Charting and modeling molecular pathways for developing novel therapeutic strategies in melanoma treatment. <\/strong>An extensive melanoma molecular characterization is ongoing in order to identify molecular biomarkers and\/or networks associated to its progression which could be exploited for the development of innovative and efficacious therapeutic strategies.<\/p><p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-12508\" src=\"http:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/caputo1.png\" alt=\"\" width=\"933\" height=\"939\" srcset=\"https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/caputo1.png 933w, https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/caputo1-298x300.png 298w, https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/caputo1-150x150.png 150w, https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/caputo1-768x773.png 768w\" sizes=\"(max-width: 933px) 100vw, 933px\" \/><\/p><p>These studies have already contributed to the identification of a novel melanoma-associated molecular pathway, where Ran, Aurora Kinase A (AurkA) and TERT were up-regulated while c-myc and PTEN were down-regulated (Caputo E et al., Cancer Letters 2015, 357: 286-296). Starting from these data, we have demonstrated that AurkA inhibitors plus MEK inhibitors or in triple combination with B-RAF inhibitors might offer a therapeutic alternative for patients without B-RAF mutations or for B-RAF mutated melanomas, respectively (Caputo E et al., Journal Translational Medicine 2014, 12: 216).<\/p><p><strong><img decoding=\"async\" class=\"alignnone wp-image-12539\" src=\"http:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/images.png\" alt=\"\" width=\"23\" height=\"23\" srcset=\"https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/images.png 225w, https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/images-150x150.png 150w\" sizes=\"(max-width: 23px) 100vw, 23px\" \/> Exploring drug resistance in melanoma. <\/strong>Since, melanomas develop resistance to target-based therapeutics (ie. B-RAFi, MEKi) we need to understand how melanoma cells are able to escape drug effect. We have generated melanoma cell lines resistant to Dabrafenib, a B-RAF inhibitor, and to Dabrafenib plus Trametinib, a MEK inhibitor.\u00a0 We have characterized the phenotypic properties of human melanoma cells resistant to dabrafenib (Cordaro et al. Oncology Reports 2017, 38: 2741-2751). Ongoing studies are aimed at investigating the metabolic properties of these drug-resistant cancer cells with the purpose to use both phenotype and metabolic profiling data to identify new targets for biological drugs development.<\/p><p><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-12509 aligncenter\" src=\"http:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/caputo2.png\" alt=\"\" width=\"725\" height=\"495\" srcset=\"https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/caputo2.png 725w, https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/caputo2-300x205.png 300w, https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/caputo2-474x324.png 474w\" sizes=\"(max-width: 725px) 100vw, 725px\" \/><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-12575 aligncenter\" src=\"http:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/Schermata-2022-02-03-alle-12.37.18.png\" alt=\"\" width=\"359\" height=\"28\" srcset=\"https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/Schermata-2022-02-03-alle-12.37.18.png 851w, https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/Schermata-2022-02-03-alle-12.37.18-300x23.png 300w, https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/Schermata-2022-02-03-alle-12.37.18-768x60.png 768w\" sizes=\"(max-width: 359px) 100vw, 359px\" \/><\/p><p><strong><img decoding=\"async\" class=\"alignnone wp-image-12539\" src=\"http:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/images.png\" alt=\"\" width=\"23\" height=\"23\" srcset=\"https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/images.png 225w, https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/images-150x150.png 150w\" sizes=\"(max-width: 23px) 100vw, 23px\" \/> Cancer Modeling for Personalized Medicine. <\/strong>We need new strategies to better personalize drug therapies, and better approaches to combat drug resistance. Systems biology can be the common platform for classifying disease states, biological networks, and drug response.<\/p><p><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-12514 aligncenter\" src=\"http:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/caputo4.png\" alt=\"\" width=\"949\" height=\"612\" srcset=\"https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/caputo4.png 949w, https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/caputo4-300x193.png 300w, https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/caputo4-768x495.png 768w\" sizes=\"(max-width: 949px) 100vw, 949px\" \/><\/p><p>We are developing breast cancer patient derived organoids, and innovative methods for a fast characterization at molecular and phenotypic level, in order to identify molecular profiles matching disease to biology to drug to effectively treat patients. These studies are critical to identify points of vulnerability for drug targeting<\/p><p><strong><img decoding=\"async\" class=\"alignnone wp-image-12539\" src=\"http:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/images.png\" alt=\"\" width=\"23\" height=\"23\" srcset=\"https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/images.png 225w, https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/images-150x150.png 150w\" sizes=\"(max-width: 23px) 100vw, 23px\" \/> Searching for Potential Anti-Cancer Agents. <\/strong>Research and development studies are ongoing in order to identify potential anticancer agent candidates for cancer treatment deriving from vegetables (Mandrich et al., Nutrients 2020, 12, 868).<\/p><p><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-12659 aligncenter\" src=\"http:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/Anti-tumoral-drugs.jpg\" alt=\"\" width=\"1183\" height=\"1023\" srcset=\"https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/Anti-tumoral-drugs.jpg 1183w, https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/Anti-tumoral-drugs-300x259.jpg 300w, https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/Anti-tumoral-drugs-1024x886.jpg 1024w, https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2022\/01\/Anti-tumoral-drugs-768x664.jpg 768w\" sizes=\"(max-width: 1183px) 100vw, 1183px\" \/><\/p>                    <\/div>\n\t\t        \n                    <div id=\"selected-publications-tab\" class=\"clearfix eael-tab-content-item inactive\" data-title-link=\"selected-publications-tab\">\n\t\t\t\t        <ul><li><a class=\"docsum-title\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36366461\/\" data-ga-category=\"result_click\" data-ga-action=\"7\" data-ga-label=\"36366461\" data-full-article-url=\"from_term=caputo+e&amp;from_pos=7\" data-article-id=\"36366461\">SARS-CoV-2: Searching for the Missing Variants. <\/a><strong>Caputo E,<\/strong> Mandrich L. Viruses. 2022 Oct 26;14(11):2364. doi: 10.3390\/v14112364.<\/li><li><a class=\"docsum-title\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36013424\/\" data-ga-category=\"result_click\" data-ga-action=\"6\" data-ga-label=\"36013424\" data-full-article-url=\"from_term=caputo+emilia&amp;from_pos=6\" data-article-id=\"36013424\">Structural and Phylogenetic Analysis of SARS-CoV-2 Spike Glycoprotein from the Most Widespread Variants. <\/a><span class=\"docsum-authors full-authors\"><strong>Caputo E<\/strong>, Mandrich L.<\/span><span class=\"docsum-journal-citation full-journal-citation\">Life (Basel). 2022 Aug 16;12(8):1245. doi: 10.3390\/life12081245<\/span><\/li><li><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8616100\/\">Melanoma Immunotherapy and Precision Medicine in the Era of Tumor Micro-Tissue Engineering: Where Are We Now and Where Are We Going?<\/a> Varrone F, Mandrich L, <strong>Caputo E<\/strong>. Cancers (Basel)\u00a02021 Nov;\u00a013(22): 5788.<\/li><li><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7146209\/\"><em>Brassicaceae<\/em>-Derived Anticancer Agents: Towards a Green Approach to Beat Cancer.<\/a> Mandrich L, <strong>Caputo E<\/strong>. Nutrients.\u00a02020 Mar;\u00a012(3): 868.<\/li><li><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7037367\/\">The miRNAs Role in Melanoma and in Its Resistance to Therapy<\/a>. Varrone F, <strong>Caputo E<\/strong>. Int J Mol Sci.\u00a02020 Feb;\u00a021(3): 878.<\/li><li><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5780027\/\">Phenotype characterization of human melanoma cells resistant to dabrafenib<\/a>. Cordaro FG, De Presbiteris AL, Camerlingo R, Mozzillo N, Pirozzi G, Cavalcanti E, Manca A, Palmieri G, Cossu A, Ciliberto G, Ascierto PA, Travali S, Patriarca EJ, <strong>Caputo E<\/strong>. Oncol Rep.\u00a02017 Nov;\u00a038(5): 2741\u20132751.<\/li><li><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5479289\/\">A Look Inside of the Complex Pathogenesis of B-RAF(V600E)-Driven Cancer<\/a>. <strong>Caputo E<\/strong>. Theranostics.\u00a02017;\u00a07(7): 2108\u20132110.<\/li><li><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4622542\/\">c-Myc modulation: a key role in melanoma drug response<\/a>. Fico A, Alfano D, Valentino A, Vasta V, Cavalcanti E, Travali S, Patriarca EJ, <strong>Caputo E<\/strong>. Cancer Biol Ther.\u00a02015;\u00a016(9): 1375\u20131386.<\/li><li><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4277926\/\">Ran signaling in melanoma: implications for the development of alternative therapeutic strategies<\/a>. <strong>Caputo E<\/strong>, Wang E, Valentino A, Crispi S, De Giorgi V, Fico A, Ficili B, Capone M, Anniciello AM, Cavalcanti E, Botti G, Mozzillo N, Ascierto PA, Marincola FM, Travali S. Cancer Lett. 2015; 357(1): 286\u2013296.<\/li><li><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4315274\/\">AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment<\/a>. <strong>Caputo E<\/strong>, Miceli R, Motti ML, Tat\u00e9 R, Fratangelo F, Botti G, Mozzillo N, Carriero MV, Cavalcanti E, Palmieri G, Ciliberto G, Pirozzi G, Ascierto PA. J Transl Med.\u00a02014;\u00a012: 216.<\/li><li><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/12963062\/\">Methods for on-chip protein analysis.<\/a> <strong>Caputo E<\/strong>, Moharram R, Martin BM. Anal Biochem. 2003;321(1):116-24.<\/li><li><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/12755619\/\">Structural study of GCDFP-15\/gp17 in disease versus physiological conditions using a proteomic approach.<\/a> <strong>Caputo E<\/strong>, Camarca A, Moharram R, Tornatore P, Thatcher B, Guardiola J, Martin BM. Biochemistry. 2003; 42(20):6169-78.<\/li><\/ul>                    <\/div>\n\t\t        \n                    <div id=\"professional-experience-tab\" class=\"clearfix eael-tab-content-item inactive\" data-title-link=\"professional-experience-tab\">\n\t\t\t\t        <p><span style=\"color: #006293\"><strong>CURRENT POSITION(S)<\/strong><\/span><\/p><p>2021-present <span style=\"text-decoration: underline\">Responsible<\/span> of the \u2018Breast Cancer Tissues and Organoids\u2019 Biobank at CRB-IGB.\u00a0<\/p><p>2004-present\u00a0 <u>CNR Researcher. <\/u>Institute of Genetics and Biophysics-IGB-Council National of Research (CNR), Naples, Italy.<\/p><p><span style=\"color: #006293\"><strong>EDUCATION<\/strong><\/span><\/p><p>2016\u00a0\u00a0\u00a0 <u>Specialization i<\/u>n Clinical Pathology. Facolt\u00e0 di Medicina e Chirurgia\/ Dipartimento di Scienze Biomediche, Universit\u00e0 degli studi di Catania\/ Italy<\/p><p>2012\u00a0\u00a0\u00a0 <u>PhD<\/u> (Oncologia XXIV Ciclo). Facolt\u00e0 di Medicina e Chirurgia\/ Dipartimento di Scienze Biomediche, Universit\u00e0 degli studi di Catania\/ Italy. PhD Supervisor: Prof. Salvatore Travali, MD<\/p><p>1996\u00a0\u00a0\u00a0 <u>Master\u00a0of Science<\/u> in Biological Science. Facolt\u00e0 di Scienze Biologiche\/ Dipartmento di Genetica, Universit\u00e0 degli Studi di Napoli \u201cFederico II\u201d, Naples, Italy<\/p><p><span style=\"color: #006293\"><strong>PREVIOUS POSITIONS<\/strong><\/span><\/p><p>2004-2006\u00a0\u00a0\u00a0\u00a0\u00a0 <u>Director Protein Facility<\/u> laboratory, IGB-CNR, Naples, Italy.<\/p><p><span style=\"color: #006293\"><strong>FELLOWSHIPS AND AWARDS<\/strong><\/span><\/p><p><u>Fellowships<\/u><\/p><p>2006-2008\u00a0\u00a0\u00a0\u00a0\u00a0 <u>Marie Curie Fellowship TOK<\/u> (Transfer of Knowledge). National University of Ireland, National Diagnostic Center, NUIG Galway, Ireland.<\/p><p>2000-2003\u00a0\u00a0\u00a0\u00a0\u00a0 <u>Fogarty Fellowship. <\/u>NIMH, Unit on Molecular Structures, NIH, Bethesda, MD, USA.\u00a0<\/p><p>1999-2000\u00a0\u00a0\u00a0\u00a0\u00a0 <u>CNR Fellow. <\/u>IGB-CNR, Naples, Italy.<\/p><p>1996-1999 \u00a0\u00a0\u00a0\u00a0 <u>CNR Fellow. <\/u>IGB-CNR, Naples, Italy.<\/p><p><u>Awards<\/u><\/p><p>2016\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <u>ERSU Scholarship Award<\/u>, Universit\u00e0 degli studi di Catania, Italy\u00a0<\/p><p>2012\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <u>ERSU Scholarship Award<\/u>, Universit\u00e0 degli studi di Catania, Italy\u00a0<\/p><p>2004-2005\u00a0\u00a0\u00a0 <u>AIDS Award<\/u>, Istituto Superiore di Sanit\u00e0 \/ Italy<\/p><p>2004\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <u>FARE Award<\/u> (NIH), Fellows Award for Research Excellence (FARE), NIH, Bethesda, MD, USA.<\/p><p>1996 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <u>EDISU Scholarship Award<\/u>, Universit\u00e0 degli Studi di Napoli \u201cFederico II\u201d, Italy<\/p><p>1996\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <u>FIAT Award<\/u>, FIAT, Italy.<\/p><p><strong><span style=\"color: #006293\">TEACHING ACTIVITIES<\/span> <\/strong><\/p><p>2012-2013\u00a0\u00a0\u00a0 <strong>Teacher<\/strong> \u2013 Processi innovativi di sintesi biomolecolare applicata a tecniche di epigenetica, Dipartimento Scienze Chimiche e Tecnologie dei Materiali (CNR) \/ Istituto di Biochimica delle Proteine (IBP) \/Istituto di Chimica Biomolecolare (ICB) &amp; Cosvitec Soc Cons arl, Italy.<\/p><p>2004-2006\u00a0\u00a0\u00a0 <strong>Teacher<\/strong> \u2013 Protein Purification Methods, Universit\u00e0 degli Studi di Napoli \u2018Federico II\u2019 &amp; CNR, Italy<\/p><p>2002-2003\u00a0\u00a0\u00a0 <strong>Teacher<\/strong> \u2013 Proteinchip arrays and its application, BioTrac 25 Courses, National Institute of Health, NIH, Bethesda, MD, USA.<\/p><p><span style=\"color: #006293\"><strong>INSTITUTIONAL RESPONSIBILITIES <\/strong><\/span><\/p><p>2020-present\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <strong>\u00a0 Member of IGB Council<\/strong>, Institute of Genetics and Biophysics-Council National of Research (CNR), Italy<\/p><p><strong><span style=\"color: #006293\">REVIEWING ACTIVITIES<\/span> <\/strong><\/p><p>2017-present \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <strong>Editorial Board Member<\/strong>, Argomenti di Oncologia Geriatrica, Edisciences<\/p><p>2009-present \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PRIN projects<strong> Expert Reviewer<\/strong>, Ministery of Education, University and Research (<strong>MIUR<\/strong>), Italy<\/p><p><strong><span style=\"color: #006293\">MEMBERSHIPS OF SCIENTIFIC SOCIETIES<\/span> <\/strong><\/p><p>2017-present<strong> \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Co-founder<\/strong> of <strong>HIGGS Senology Responsibility, <\/strong>Non-Profit Foundation to fight against Breast Cancer, Italy<\/p><p><strong><span style=\"color: #006293\">MAJOR COLLABORATIONS<\/span> <\/strong><\/p><p><strong>L<span style=\"color: #000000\">ucia Miranda<\/span><span style=\"color: #000000\">, MD<\/span><\/strong>. <span style=\"color: #006293\"><em>Biobanking of Breast Cancer patient-derived living organoids. <\/em><span style=\"color: #000000\">Azienda Ospedaliera dei Colli \u2013 Monaldi<\/span><\/span><\/p><p><span style=\"color: #000000\"><strong>Annalisa Fico, <\/strong><\/span><span style=\"color: #006293\"><span style=\"color: #000000\"><strong>PhD<\/strong><\/span>. <em>Biobanking of Breast Cancer patient-derived living organoids. <\/em><span style=\"color: #000000\">IGB\/CNR<\/span><\/span><\/p><p><strong>Luigi Mandrich, PhD<\/strong>. <span style=\"color: #006293\"><em>Development of novel anti-cancer drugs from vegetable sources. <\/em><span style=\"color: #000000\">IRET \/ CNR<\/span><\/span><\/p><p><strong>Luigi Panico, MD<\/strong>. <span style=\"color: #006293\"><em>Drug Resistance in Melanoma. <\/em><span style=\"color: #000000\">Azienda Ospedaliera dei Colli \u2013 Monaldi<\/span><\/span><\/p><div class=\"notranslate\">\u00a0<\/div>                    <\/div>\n\t\t        \n                    <div id=\"research-group-tab\" class=\"clearfix eael-tab-content-item inactive\" data-title-link=\"research-group-tab\">\n\t\t\t\t        <p><div class=\"tmm tmm_research-group-caputo\"><div class=\"tmm_2_columns tmm_wrap tmm_plugin_f\"><span class=\"tmm_two_containers_tablet\"><\/span><div class=\"tmm_container\"><div class=\"tmm_member\" style=\"border-top:#006293 solid 5px;\"><div class=\"tmm_photo tmm_pic_research-group-caputo_0\" style=\"background: url(https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2023\/03\/Emanuela-Carbone.jpg); margin-left: auto; margin-right:auto; background-size:cover !important;\"><\/div><div class=\"tmm_textblock\"><div class=\"tmm_names\"><span class=\"tmm_fname\">Emanuela<\/span> <span class=\"tmm_lname\">Carbone<\/span><\/div><div class=\"tmm_job\">Tesista<\/div><div class=\"tmm_scblock\"><\/div><\/div><\/div><div class=\"tmm_member\" style=\"border-top:#006293 solid 5px;\"><div class=\"tmm_photo tmm_pic_research-group-caputo_1\" style=\"background: url(https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2023\/03\/Clara-Fiorentino-scaled.jpg); margin-left: auto; margin-right:auto; background-size:cover !important;\"><\/div><div class=\"tmm_textblock\"><div class=\"tmm_names\"><span class=\"tmm_fname\">Clara<\/span> <span class=\"tmm_lname\">Fiorentino<\/span><\/div><div class=\"tmm_job\">Tesista<\/div><div class=\"tmm_scblock\"><\/div><\/div><\/div><span class=\"tmm_two_containers_tablet\"><\/span><\/div><span class=\"tmm_columns_containers_desktop\"><\/span><div class=\"tmm_container\"><div class=\"tmm_member\" style=\"border-top:#006293 solid 5px;\"><div class=\"tmm_photo tmm_pic_research-group-caputo_2\" style=\"background: url(https:\/\/www.igb.cnr.it\/wp-content\/uploads\/2023\/03\/Unknown.jpeg); margin-left: auto; margin-right:auto; background-size:cover !important;\"><\/div><div class=\"tmm_textblock\"><div class=\"tmm_names\"><span class=\"tmm_fname\">Melina<\/span> <span class=\"tmm_lname\">Stathoupoulou<\/span><\/div><div class=\"tmm_job\">Studente Erasmus<\/div><div class=\"tmm_scblock\"><\/div><\/div><\/div><div style=\"clear:both;\"><\/div><\/div><\/div><\/div><\/p>                    <\/div>\n\t\t                    <\/div>\n        <\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Emilia Caputo Researcher \u00a0 +39 081 6132307\/446\/455 \u00a0 emilia.caputo@igb.cnr.it Molecular Oncology Keywords: Breast Cancer Patient-derived Organoids; Multicellular Spheroids (MCSs); Breast Cancer; gp17\/GCDFP-15\/SABP\/PIP; BRAF-driven Cancers; Melanoma; Drug Resistance in Cancer; Targeted Therapy; Biomarker Discovery. \u00a0 Research Interest Selected Publications Professional Experience Research Group My research program focuses on cancer, by integrating broad disciplines centered on translational [&hellip;]<\/p>\n","protected":false},"author":16,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"cybocfi_hide_featured_image":"","footnotes":""},"class_list":["post-2497","page","type-page","status-publish","czr-hentry"],"_links":{"self":[{"href":"https:\/\/www.igb.cnr.it\/index.php\/wp-json\/wp\/v2\/pages\/2497","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.igb.cnr.it\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.igb.cnr.it\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.igb.cnr.it\/index.php\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/www.igb.cnr.it\/index.php\/wp-json\/wp\/v2\/comments?post=2497"}],"version-history":[{"count":194,"href":"https:\/\/www.igb.cnr.it\/index.php\/wp-json\/wp\/v2\/pages\/2497\/revisions"}],"predecessor-version":[{"id":18765,"href":"https:\/\/www.igb.cnr.it\/index.php\/wp-json\/wp\/v2\/pages\/2497\/revisions\/18765"}],"wp:attachment":[{"href":"https:\/\/www.igb.cnr.it\/index.php\/wp-json\/wp\/v2\/media?parent=2497"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}